We document the binding features of two compounds (ZINC000014780728 (-11.0 kcal/mol) and ZINC000014762512 (-10.8 kcal/mol)) with HER2 relative to the reference compound (lapatinib (-10.2 kcal/mol)) for further consideration in the context of cancer. The gene discussed is ERBB2; the disease is cancer.